Chronic myelogenous leukemia is a myeloproliferative neoplasm that is driven by a BCR-Abl fusion gene, resulting in constitutive activation of a tyrosine-protein kinase BCR-ABL1 [103]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.